MainboardGMP
LIVE
LIVE GMP
MakeMyTrip (India) Ltd₹0·Sagar Defence Engineering Ltd₹0·Encube Ethicals Ltd₹0·Arjun Jewellers Ltd₹0·Atomberg Technologies Ltd₹0·GNI Infrastructure Ltd₹0·Punjab Carbonic Ltd₹0·Ratnadeep Retail Ltd.₹0·IFL Finance Ltd.₹0·J Pan Tubular Components Ltd₹0·MakeMyTrip (India) Ltd₹0·Sagar Defence Engineering Ltd₹0·Encube Ethicals Ltd₹0·Arjun Jewellers Ltd₹0·Atomberg Technologies Ltd₹0·GNI Infrastructure Ltd₹0·Punjab Carbonic Ltd₹0·Ratnadeep Retail Ltd.₹0·IFL Finance Ltd.₹0·J Pan Tubular Components Ltd₹0·
Home › IPOs › Sawastika Castal Ltd. › Subscription
SA
Sawastika Castal Ltd.
CLOSED BSE SME Fixed Price IPO Fresh Capital Sawastika Castal IPO GMP
GREY MARKET PREMIUM
₹ 0
No premium data
EST. LISTING PRICE
₹65
Issue Price: ₹ 65
Issue Price
₹65
Face Value
₹10
Lot Size
2,000 shares
Open Date
21 Jul 2025
Close Date
23 Jul 2025
Allotment
24 Jul 2025
Listing Date
28 Jul 2025
Exchange
BSE SME

Sawastika Castal IPO Details: Price, Dates & Financials

The Sawastika Castal IPO GMP strength score is 8.5 out of 10, which the dashboard rates as Strong. The Sawastika Castal IPO valuation is tagged Good. The Sawastika Castal IPO NII/HNI category is reserved for 47.41% of the offer. The Sawastika Castal IPO Retail (RII) category is reserved for 47.5% of the offer. Live subscription numbers for the Sawastika Castal IPO are not yet available, and amounts are calculated at the upper price band of ₹65.

IPO Analytics Dashboard
LIVE
Sawastika Castal IPO GMP Insights
👤
Retail Demand
Strong
💼
HNI Interest
Strong
📊
Valuation
Good
Sawastika Castal IPO GMP Strength Score
9 / 10 Strong
0–3 Weak 3–6 Moderate 6–8 Good 8–10 Strong
Sawastika Castal IPO Category-wise Subscription Shares offered, bid & amount
Category Sub (x) Offered Bid For
💼 NII / HNI — 1,026,000 (47%) —
👤 Retail (RII) — 1,028,000 (48%) —
📊 Market Maker — 110,000 (5%) —
Σ Total — 2,164,000 (100%) —

* Amount calculated at upper price band (₹65) ·  ** Total includes all investor categories

Subscription Overview Share allocation by investor category
💼
NII / HNI ? 1,026,000 (47%)
47%
👤
Retail (RII) ? 1,028,000 (48%)
48%
📊
Market Maker ? 110,000 (5%)
5%
Total Shares Offered 2,164,000 (100%)
Sawastika Castal IPO Application Sizing Minimum investment by category
👤 Retail Investors ?
Min. Lots 2
Shares / Lot 4,000
Min. Investment 260,000
💼 HNI Investors ?
Min. Lots 3
Min. Shares 6,000
Min. Investment 390,000
Sawastika Castal IPO Valuation — EPS & P/E Pre & post-issue metrics
Pre-Issue EPS ?
₹ 4
Post-Issue EPS ?
₹ 3
Pre-Issue P/E ?
15 x
Post-Issue P/E ?
20 x
Sawastika Castal IPO Timeline & Key Dates
  1. 1 💳 Initiation of Refund 25 Jul 2025
  2. 2 📂 Credit of Shares to Demat 25 Jul 2025
Investor Interpretation
  • Retail allocation is strong at 48% of the total offering.
  • HNI/NII demand is strong at 47%.
  • The IPO P/E of 20x reflects a good valuation relative to typical market ranges.
  • Pre-issue EPS of ₹4 compares to post-issue EPS of ₹3 after dilution.

This IPO shows strong fundamentals and healthy investor demand. Research the business model and compare with sector peers before applying.

Sawastika Castal IPO Subscription FAQs
Subscription data for Sawastika Castal IPO is not available right now. Numbers are updated here during the bidding window.
In Sawastika Castal IPO, retail investors can apply for a minimum of 2 lot(s) (₹260,000); HNI/sNII minimum 3 lots (₹390,000).
Shares offered by category — Retail 1,028,000 (48%) shares.
Sawastika Castal IPO valuation — pre-issue EPS ₹4.39, post-issue EPS ₹3.23, pre-issue P/E 14.8, post-issue P/E 20.14.
Subscription is shares bid for divided by shares offered in that category. If 10 lakh shares are offered and 50 lakh are bid for, the category is subscribed 5 times. Final numbers are confirmed after the bidding closes.
The NII category covers investors applying for shares outside the retail investor category, while HNI commonly refers to high-value investors within the NII category. Understanding the Sawastika Castal IPO's NII and HNI subscription levels helps investors assess demand for the Sawastika Castal IPO and overall investor interest.

GMP and IPO data are unofficial and for information only — not investment advice. Read the full disclaimer.